Schedule 13D ownership disclosure
aTYR PHARMA INC
Security class unavailable · CUSIP: 002120103
Event date: 2018-06-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-006343
- Form type
- SC 13D
- Filer
- Sofinnova Venture Partners IX, L.P.
- CIK
- CIK 1612133
- Filed
- Feb 12, 2019
- Reporting period
- Jun 05, 2018
- Description
- Schedule 13D beneficial ownership